CN Patent

CN116322653A — 包括酞嗪酮衍生物的药物组合物

Assigned to Edith Inc · Expires 2023-06-23 · 3y expired

What this patent protects

本发明涉及一种稳定的药物组合物，其包括具有优异活性的作为聚(ADP‑核糖)聚合酶抑制剂的酞嗪酮衍生物。

USPTO Abstract

本发明涉及一种稳定的药物组合物，其包括具有优异活性的作为聚(ADP‑核糖)聚合酶抑制剂的酞嗪酮衍生物。

Drugs covered by this patent

Patent Metadata

Patent number: CN116322653A
Jurisdiction: CN
Classification: —
Expires: 2023-06-23
Drug substance claim: No
Drug product claim: No
Assignee: Edith Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.